BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38700373)

  • 61. [Autoimmune lymphoproliferative syndrome: a case report].
    Youssif HB; Ailal F; Benhsaien I; Bakkouri JE; Jeddane L; Maani KE; Bousfiha AA
    Pan Afr Med J; 2022; 43():61. PubMed ID: 36523284
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation.
    Revel-Vilk S; Fischer U; Keller B; Nabhani S; Gámez-Díaz L; Rensing-Ehl A; Gombert M; Hönscheid A; Saleh H; Shaag A; Borkhardt A; Grimbacher B; Warnatz K; Elpeleg O; Stepensky P
    Clin Immunol; 2015 Jul; 159(1):84-92. PubMed ID: 25931386
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Circulating Soluble Fas and Fas Ligand Levels Are Elevated in Children with Nonalcoholic Steatohepatitis.
    Alkhouri N; Alisi A; Okwu V; Matloob A; Ferrari F; Crudele A; De Vito R; Lopez R; Feldstein AE; Nobili V
    Dig Dis Sci; 2015 Aug; 60(8):2353-9. PubMed ID: 25764498
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical Features.
    Kurita D; Shiba N; Ohya T; Murase A; Shimosato Y; Yoshitomi M; Hattori S; Sasaki K; Nishimura K; Tsujimoto SI; Takeuchi M; Tanoshima R; Kanegane H; Kitagawa N; Ito S
    J Clin Immunol; 2023 Nov; 43(8):1992-1996. PubMed ID: 37644277
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Autoimmune Lymphoproliferative Syndrome Masquerading as Posttransplant Lymphoproliferative Disorder.
    Jeffreys SM; Levy RA; Crary SE
    J Pediatr Hematol Oncol; 2018 Jul; 40(5):e305-e308. PubMed ID: 28991130
    [TBL] [Abstract][Full Text] [Related]  

  • 66. FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene.
    Miano M; Cappelli E; Pezzulla A; Venè R; Grossi A; Terranova P; Palmisani E; Maggiore R; Guardo D; Lanza T; Calvillo M; Micalizzi C; Pierri F; Vernarecci C; Beccaria A; Corsolini F; Lanciotti M; Russo G; Ceccherini I; Dufour C; Fioredda F
    Br J Haematol; 2019 Nov; 187(4):502-508. PubMed ID: 31309545
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical features and therapeutic challenges of cytopenias belonging to alps and alps-related (ARS) phenotype.
    Palmisani E; Miano M; Micalizzi C; Calvillo M; Pierri F; Terranova P; Lanza T; Lanciotti M; Riccardi F; Todiere A; Zanardi S; Caviglia I; Dufour C; Fioredda F
    Br J Haematol; 2019 Mar; 184(5):861-864. PubMed ID: 29527658
    [No Abstract]   [Full Text] [Related]  

  • 68. Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.
    George LA; Teachey DT
    Paediatr Drugs; 2016 Aug; 18(4):261-72. PubMed ID: 27139496
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
    Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
    J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy.
    López-Nevado M; Ortiz-Martín J; Serrano C; Pérez-Saez MA; López-Lorenzo JL; Gil-Etayo FJ; Rodríguez-Frías E; Cabrera-Marante O; Morales-Pérez P; Rodríguez-Pinilla MS; Manso R; Salgado-Sánchez RN; Cerdá-Montagud A; Quesada-Espinosa JF; Gómez-Rodríguez MJ; Paz-Artal E; Muñoz-Calleja C; Arranz-Sáez R; Allende LM
    J Clin Immunol; 2023 Jan; 43(1):165-180. PubMed ID: 36066697
    [TBL] [Abstract][Full Text] [Related]  

  • 71. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.
    Teachey DT
    Curr Opin Pediatr; 2012 Feb; 24(1):1-8. PubMed ID: 22157362
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Thymic functions and gene expression profile distinct double-negative cells from single positive cells in the autoimmune lymphoproliferative syndrome.
    Lev A; Simon AJ; Amariglio N; Rechavi G; Somech R
    Autoimmun Rev; 2012 Aug; 11(10):723-30. PubMed ID: 22273982
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome.
    Carrasquillo JA; Chen CC; Price S; Whatley M; Avila NA; Pittaluga S; Jaffe ES; Rao VK
    Clin Nucl Med; 2019 Dec; 44(12):949-955. PubMed ID: 31689275
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A unique phenotype of longitudinal extensive transverse myelitis in autoimmune lymphoproliferative syndrome.
    Dekeyser C; Naesens L; Offner F; De Vriendt C; Schauwvlieghe A; Kerre T; Laureys G
    J Neuroimmunol; 2022 Jun; 367():577866. PubMed ID: 35453041
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Autoimmune lymphoproliferative syndrome].
    Rodrigues V; Conde M; Figueiredo A; Vasconcelos J; Dias A
    Acta Med Port; 2011; 24(5):833-6. PubMed ID: 22525637
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.
    Gámez-Díaz L; Grimbacher B
    Biomed J; 2021 Aug; 44(4):400-411. PubMed ID: 34384744
    [TBL] [Abstract][Full Text] [Related]  

  • 77. IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes.
    Boggio E; Clemente N; Mondino A; Cappellano G; Orilieri E; Gigliotti CL; Toth E; Ramenghi U; Dianzani U; Chiocchetti A
    Blood; 2014 Feb; 123(8):1178-86. PubMed ID: 24363402
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.
    Boggio E; Aricò M; Melensi M; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
    Pediatrics; 2013 Oct; 132(4):e1052-8. PubMed ID: 24043286
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
    Oliveira JB; Bleesing JJ; Dianzani U; Fleisher TA; Jaffe ES; Lenardo MJ; Rieux-Laucat F; Siegel RM; Su HC; Teachey DT; Rao VK
    Blood; 2010 Oct; 116(14):e35-40. PubMed ID: 20538792
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.
    Bettinardi A; Brugnoni D; Quiròs-Roldan E; Malagoli A; La Grutta S; Correra A; Notarangelo LD
    Blood; 1997 Feb; 89(3):902-9. PubMed ID: 9028321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.